Rothstein, M., “Time to End the Use of Genetic Test Results in Life Insurance Underwriting,” Journal of Law, Medicine & Ethics 46, no. 3 (2018): 794–801, at 797.CrossRefGoogle ScholarPubMed

Berry, R., “The Human Genome Project and the End of Insurance,” University of Florida Journal of Law and Public Policy 7, no. 2 (1996): 205-56, at 205; R. Strohmenger and A. Wambach, “Adverse Selection and Categorical Discrimination in the Health Insurance Markets: The Effects of Genetic Tests,” Journal of Health Economics 19 (200): 197-218.Google ScholarPubMed

Akerlof, G., “The Market for ‘Lemons’: Quality Uncertainty and the Market Mechanism,” Quarterly Journal of Economics 84, no. 3 (1970): 488–500, at 84.CrossRefGoogle Scholar

Hendren, N., “Private Information and Insurance Rejections,” Econometrica 81, no. 5 (2013): 1713–1762.Google ScholarPubMed

Cutler, D.M. and Reber, S.J., “Paying for Health Insurance: The Trade-Off between Competition and Adverse Selection,” The Quarterly Journal of Economics 113, no. 2 (1998): 433–466.CrossRefGoogle Scholar

Durnin, M. and Hoy, M., “Third Party Sharing of Genetic Information,” in Hostiuc, S., ed., Clinical Ethics at the Crossroads of Genetic and Reproductive Technologies (Academic Press, 2018): at 385–406.Google Scholar

Roy, D. and Dorak, M. Tevfik, Environmental Factors, Genes, and Development of Human Cancers (New York: Springer, 2010): 1–520.CrossRefGoogle Scholar

Otlowski, M., Taylor, S., and Bombard, Y., “Genetic Discrimination: International Perspectives,” Annual Review of Genomics and Human Genetics 13 (2012): 433–454, available at <https://www.annualreviews.org/doi/full/10.1146/annurev-genom-090711-163800?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed> (last visited November 2, 2021).CrossRefGoogle ScholarPubMed

Nill, A., Laczniak, G., and Thistle, P., “The Use of Genetic Testing Information in the Insurance Industry: An Ethical and Societal Analysis of Public Policy Options,” Journal of Business Ethics 156, no. 1 (2019): 105–121.CrossRefGoogle Scholar

Joly, Y., Baker, M., and Huynh, M., “Genetic Discrimination in Private Insurance: Global Perspectives,” New Genetics and Society 29, no. 4 (2010): 351–368; A. Wauters and I. Van Hoyweghen, “Concerns about Genetic Discrimination after Regulation: A Qualitative Study of the Situation Regarding BRCA and Huntington’s Disease in Belgium,” Laws 7 (2018): 17; Otlowski et al., supra note 8.CrossRefGoogle Scholar

Dep’t of Health & Social Care, “Concordat and Moratorium on Genetics and Insurance,” Her Majesty’s Government and Association of British Insurers,” UK 2004, available at <https://www.abi.org.uk/globalassets/sitecore/files/documents/publications/public/2014/genetics/concordat-and-moratorium-on-genetics-and-insurance.pdf> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Otlowski et al., supra note 8.Google Scholar

Stirton, R., “Insurance, Genetic Information and the Future of Industry Self-Regulation in the UK,” Law, Innovation and Technology 4, no. 2 (2012): 212-237 at 212.CrossRefGoogle Scholar

Daykin, C.D. et al., “Genetics and Insurance–Some Social Policy Issues,” British Actuarial Journal 9, no. 4 (2003): 787–830, at 815.CrossRefGoogle Scholar

Tiller, J., Otlowski, M., and Lacaze, P., “Should Australia Ban the Use of Genetic Test Results in Life Insurance?” Frontiers in Public Health 5 (2017): 330, available at <https://www.frontiersin.org/articles/10.3389/fpubh.2017.00330/full> (last visited November 2, 2021).CrossRefGoogle ScholarPubMed

Financial Services Council, FSC Standard No. 11: Moratorium on Genetic Tests in Life Insurance, June 21, 2019, available at <https://www.fsc.org.au/resources-category/standard/1779-standard-11-moratorium-on-genetic-tests-in-life-insurance/file> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Financial Services Council, “Genetic Tests and Applying for Life Insurance – Key Facts,” available at <https://www.fsc.org.au/resources-category/publication/1785-moratorium-key-facts/file> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Genetic Non-Discrimination Act, S.C. 2017, C 3, available at <https://laws-lois.justice.gc.ca/PDF/G-2.5.pdf> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Id.Google Scholar

Lombardo, M., “The Impact of Genetic Testing on Life Insurance Mortality,” Society of Actuaries, 2018, available at <https://www.soa.org/globalassets/assets/files/resources/research-report/2018/2018-impact-genetic-testing-report.pdf> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Canadian Coal. for Genetic Fairness v. Attorney Gen. of Can., 2020 SCC 17 (Can.), available at <https://decisions.scc-csc.ca/scc-csc/scc-csc/en/item/18417/index.do> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Prince, A. and Waterstone, M., “The Genetic Information Nondiscrimination Act (GINA) of 2008,” in Quinn, G., Paor, A. De, Blanck, P., eds., Genetic Discrimination: Transatlantic Perspectives on the Case for a European-level Response (New York: Routledge, 2015): at 114.Google Scholar

Roberts, J., “The Genetic Information Non Discrimination Act as an Antidiscrimination Law,” Notre Dame Law Review 86, no. 2 (2011): 597–648, at 597; S. Baruch and K. Hudson, “Civilian and Military Genetics: Nondiscrimination Policy in a Post- GINA World,” American Journal of Human Genetics 83, no. 4 (2008): 435-444, at 435.Google Scholar

Wolf, L., Brown, E., Kerr, R., Razick, G., Tanner, G., Duvall, B., Jones, S., Brackney, J., and Posada, T., “The Web of Legal Protections for Participants in Genomic Research,” Health Matrix 29 (2019): 1–112.Google ScholarPubMed

Golinghorst, D. and Prince, A., “A survey of U. S. State Insurance Commissioners Concerning Genetic Testing and Life Insurance: Redux at 27,” Journal of Genetic Counseling 29 (2020): 928–935.CrossRefGoogle ScholarPubMed

Lewis, A., Green, R., and Prince, A., “Long-Awaited Progress in Addressing Genetic Discrimination in the United States,” Genetics in Medicine (2020): 1–3.CrossRefGoogle Scholar

Disability Act 2005 (Act No. 14 Part 4/2005) (Ir.), available at < http://www.irishstatutebook.ie/eli/2005/act/14/section/41/enacted/en/html#part4> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Disability Act 2005 (Act No. 14 § 42/2005)(Ir.), available at <http://www.irishstatutebook.ie/eli/2005/act/14/section/42/enacted/en/html> (last visited November 1, 2021).+(last+visited+November+1,+2021).>Google Scholar

de Paor, A., “Direct to Consumer Genetic Testing – Law and Policy Concerns in Ireland,” Irish Journal of Medical Science 189, no. 3 (2018): 575–584, at 579.CrossRefGoogle Scholar

de Paor, A., “The Irish Legislative Response to Genetic Discrimination – An Analysis of Part 4 of the Disability Act 2005: Time for Reform?” Dublin University Law Journal 38 (2015): 129–156, at 141–142.Google Scholar

Id., at 144.Google Scholar

Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of such Data, and Repealing Directive 95/46/EC, 2016 O.J. (L 119) 1.Google Scholar

de Paor, supra note 30.Google Scholar

Avraham, R., Logue, K., and Schwarcz, D., “Towards a Universal Framework for Insurance Anti-Discrimination Laws,” Connecticut Insurance Law Journal 21 (2014): 1–52, at 8; M. Hoy and M. Ruse, “Regulating Genetic Information in Insurance Markets,” Risk Management and Insurance Review 8, no. 2 (2007): 211-237, at 214.Google Scholar

Association of British Insurers and Department of Health and Social Care, Her Majesty’s Government, Guidance: Code on genetic testing and insurance (October 23, 2018), available at <https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/751230/code-on-genetic-testing-and-insurance.pdf> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Macdonald, A., “Genetics and Insurance: What Have We Learned So Far?” Scandinavian Actuarial Journal (2003): 324–348.CrossRefGoogle Scholar

Falconer, D.S., ed., Introduction to Quantitative Genetics (Pearson Education Limited, 1996).Google Scholar

Hacariz, O., Kleinow, T., and Macdonald, A., “Genetics, Insurance and Hypertrophic Cardiomyopathy,” Scandinavian Actuarial Journal (2020): 1–28.Google Scholar

Macdonald, A. and Yu, F., “The Impact of Genetics on Insurance: Conclusions from the ‘Bottom-up’ Modelling Programme,” ASTIN Bulletin 41 (2011): 343–376.Google Scholar

Howard, R., Report to Canadian Institute of Actuaries Research Committee, Genetic Testing Model: If Underwriters Had No Access to Known Results, Document 214082 (July 10, 2014), available at <http://cia-ica.ca/docs/default-source/2014/214082e.pdf> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Crocker, K. and Snow, A., “The Efficiency of Competitive Equilibria in Insurance Markets with Asymmetric Information,” Journal of Public Economics 26, no. 2 (1985): 207–219.CrossRefGoogle Scholar

Rothschild, C., “The Efficiency of Categorical Discrimination in Insurance Markets,” Journal of Risk and Insurance 78, no. 2 (2011): 267–285.CrossRefGoogle Scholar

Hoy, M. and Durnin, M., “The Potential Economic Impact of a Ban on the Use of Genetic Information for Life and Health Insurance,” Office of the Privacy Commissioner of Canada (2012).Google Scholar

Hoy, M., “Categorizing Risk in the Insurance Industry,” Quarterly Journal of Economics 97, no. 2 (1982): 321–336; M. Hoy, “Risk Classification and Social Welfare,” The Geneva Papers on Risk and Insurance – Issues and Practice 31 (2006): 245-269.CrossRefGoogle Scholar

Thomas, G., “Book Review: Loss Coverage,” The Actuary, November, 29, 2017, at 5, available at <https://onlinelibrary.wiley.com/doi/full/10.1111/jori.12262> (last visited November 2, 2021).+(last+visited+November+2,+2021).>Google Scholar

Doherty, N. and Thistle, P., “Adverse Selection with Endogenous Information in Insurance Markets,” Journal of Public Economics 63, no. 1 (1996): 83–102.CrossRefGoogle Scholar

Dionne, G. and Rothschild, C., “Economic Effects of Risk Classification Bans,” Geneva Risk and Insurance Review 39 (2014): 184–221; Strohmenger and Wambach, supra note 2.Google Scholar

Hoel, M., Iversen, T., Nilssen, T., and Vislie, J., “Genetic Testing in Competitive Insurance Markets with Repulsion From Chance: A Welfare Analysis,” Journal of Health Economics 25, no. 5 (2006): 847–860.CrossRefGoogle Scholar

Doherty, N. and Posey, L., “On the Value of a Checkup: Adverse Selection, Moral Hazard and the Value of Information,” Journal of Risk and Insurance 65, no. 2 (1998): 189–211; F. Barigozzi and D. Henriet, “Genetic Information: Comparing Alternative Regulatory Approaches When Prevention Matters,” Journal of Public Economic Theory 13, no. 1 (2011): 23-46; R. Peter, A. Richter, and P. Thistle, “Endogenous Information, Adverse Selection, and Prevention: Implications for Genetic Testing Policy,” Journal of Health Economics 55 (2017): 95-107.CrossRefGoogle Scholar

Posey, L. and Thistle, P., “Genetic Testing and Genetic Discrimination: Public Policy When Insurance Becomes ‘Too Expensive,’” Journal of Health Economics 77 (2021): 102441.CrossRefGoogle ScholarPubMed

Hoy, M. and Polborn, M., “The Value of Genetic Information in the Life Insurance Market,” Journal of Public Economics 78, no. 3 (2000): 235–252.CrossRefGoogle Scholar

Polborn, M., Hoy, M., and Sadanand, A., “Advantageous Effects of Regulatory Adverse Selection in the Life Insurance Market,” Economic Journal 116, no. 508 (2006): 327–354.CrossRefGoogle Scholar

Subramanian, K., Lemare, J., Hershey, J., Pauly, M., Armstrong, K., and Asch, D., “Estimating Adverse Selection Costs from Genetic Testing for Breast and Ovarian Cancer: The Case of Life Insurance,” Journal of Risk and Insurance 66, no. 4 (1999): 531–550, available at <https://www.jstor.org/stable/253862?casa_token=01CdUvEx9f4AAAAA:1g8cDicHN9PXZvHJ3jaHXoSvANrSwW7C9y2bZZv-0uuHh1HUC21-iVP8U3S2BeK_kAjuQdBYa3oGJf6hMV8SwgSXpecqYCiw9hhkporrHCLdd-0PD1U5&seq=1#metadata_info_tab_contents> (last visited November 3, 2021).CrossRefGoogle Scholar

Hoy, M. and Witt, J., “Welfare Effects of Banning Genetic Information in the Life Insurance Market: The Case of BRCA 1/2 Genes,” Journal of Risk and Insurance 74, no. 3 (2007): 523–546.CrossRefGoogle Scholar

Viswanathan, K., Lemaire, J., Withers, K., Armstrong, K., Baumritter, A., Hershey, J., Pauly, M., and Asch, D., “Adverse Selection in Term Life Insurance Purchasing Due to the BRCA 1/2 Genetic Test and Elastic Demand,” Journal of Risk and Insurance 74, no. 1 (2007): 65–86.CrossRefGoogle Scholar

Howard, supra note 40.Google Scholar

Lombardo, supra note 20.Google Scholar

Armstrong, K., Weber, B., FitzGerald, G., Hershey, J., Pauly, M., Lemaire, J., Subramanian, K., and Asch, D., “Life Insurance and Breast Cancer Risk Assessment: Adverse Selection, Genetic Testing Decisions, and Discrimination,” American Journal of Medical Genetics 120A, no. 3 (2003): 359–364, available at <https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.a.20025> (last visited November 3, 2021).CrossRefGoogle ScholarPubMed

Id. Google Scholar

Zick, C., Smith, K., Mayer, R., and Botkin, J., “Genetic Testing, Adverse Selection, and the Demand for Life Insurance,” American Journal of Medical Genetics 93, no. 1 (2000): 29–39, available at <https://doi.org/10.1002/1096-8628(20000703)93:1<29::AID-AJMG6>3.0.CO;2-K> (last visited November 3, 2021).3.0.CO;2-K>CrossRefGoogle ScholarPubMed

Oster, E., Shoulson, I., Quaid, K., and Dorsey, E., “Genetic Adverse Selection: Evidence from Long-Term Care Insurance and Huntington Disease,” Journal of Public Economics 94, no. 11-12 (2010): 1041–1050, available at <https://www.sciencedirect.com/science/article/abs/pii/S0047272710000745> (last visited November 3, 2021).CrossRefGoogle Scholar

Id. Google Scholar

Zick, C.D., Mathews, C.J., Roberts, J.S., Cook-Deegan, R., Pokorski, R.J., and Green, R.C., “Genetic Testing for Alzheimer’s Disease and its Impact on Insurance Purchasing Behavior,” Health Affairs 24, no. 2 (2005): 483–490.CrossRefGoogle ScholarPubMed

Id. Google Scholar

Van Oostrom, I. et al., “The Common Sense Model of Self-Regulation and Psychological Adjustment to Predictive Genetic Testing: A Prospective Study,” Psycho-Oncology 16, no. 12 (2007): 1121–1129.CrossRefGoogle ScholarPubMed

Id.; McClelland, M., Feldhof, J., Morrison, F., Gestsdottir, S., Cameron, C. et al., “Self-Regulation,” in Halfon, N., Forrest, C., Lerner, R., and Faustman, E., eds., Handbook of Life Course Health Development (New York: Springer, 2018): 275–298; C. Cameron et al., “Self-Regulation Principles Underlying Risk Perception and Decision Making within the Context of Genomic Testing,” Social and Personal Psychology Compass (2017).CrossRefGoogle Scholar

McClelland et al., supra note 67, at 275-298; Golman, R., Hagmann, D., and Loewenstein, G., “Information Avoidance,” Journal of Economic Literature 55, no. 1 (2017): 96–135.CrossRefGoogle Scholar

McClelland et al., supra note 67, at 275-298; Heck, P. R. and Meyer, M.N., “Information Avoidance in Genetic Health: Perceptions, Norms, and Preferences,” Social Cognition 37 (2019): 266–293; D. O. Case, J. E. Andrews, J. D.Johnson, and S. L. Allard, “Avoiding Versus Seeking: The Relationship of Information Seeking to Avoidance, Blunting, Coping, Dissonance, and Related Concepts,” Journal of the Medical Library Association, no. 93 (2005): 353.CrossRefGoogle Scholar

Taber, J. M., Klein, W.M., Ferrer, R.A., Lewis, K.L., Harris, P.R., Shepperd, J.A., and Biesecker, L.G., “Information Avoidance Tendencies, Threat Management Resources, and Interest in Genetic Sequencing Feedback,” Annals of Behavioral Medicine 49 (2015): 616–621.CrossRefGoogle ScholarPubMed

Caplin, A. and Leahy, J., “The Supply of Information by a Concerned Expert,” Economic Journal 114, no. 497 (2004): 487–505; B. Kőszegi, “Health Anxiety and Patient Behavior,” Journal of Health Economics 22, no. 6 (2003): 1073-1084; A. Caplin and K. Eliaz, “Aids Policy and Psychology: A Mechanism-Design Approach,” RAND Journal of Economics 34, no. 4 (2003): 631-646.CrossRefGoogle Scholar

Hoy, M., Peter, R., and Richter, A., “Take-Up for Genetic Tests and Ambiguity,” Journal of Risk and Uncertainty 48 (2014): 111–133.CrossRefGoogle Scholar

Meiser, B. and Dunn, S., “Psychological Impact of Genetic Testing for Huntington’s Disease: An Update of the Literature,” Journal of Neurology, Neurosurgery and Psychiatry 69, no. 5 (2000): 574–578.CrossRefGoogle ScholarPubMed

Oster, E., Shoulson, I., and Dorsey, E., “Optimal Expectations and Limited Medical Testing: Evidence from Huntington Disease,” American Economic Review 103, no. 2 (2013): 804–830.CrossRefGoogle Scholar

Schwartz, M.D., et al., “Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer,” Journal of Clinical Oncology 32, no. 7 (2014): 618–626.CrossRefGoogle ScholarPubMed

Desai, S. and Jena, A., “Do Celebrity Endorsements Matter? Observational Study of BRCA Gene Testing and Mastectomy Rates After Angelina Jolie’s New York Times Editorial,” British Medical Journal 355, note 6357 (2016): 1–4.Google ScholarPubMed

Fagerlin, A., Zikmund-Fisher, B., and Ubel, P., “Helping Patients Decide: Ten Steps to Better Risk Communication,” Journal of the National Cancer Institute 103 (2011): 1436–1443.CrossRefGoogle ScholarPubMed

Davis, K., Roter, D., Schmidlen, T., Scheinfeldt, L., and Klein, W., “Testing a Best Practices Risk Result Format to Communicate Genetic Risks,” Patient Education & Counseling no. 103 (2020): 1–8.Google Scholar

Oster et al., supra note 62.Google Scholar

Otlowski, M., Stranger, M., and Taylor, S., “Practices and Attitudes of Australian Employers in Relation to the Use of Genetic Information: Report on a National Study,” Comparative Labor Law and Policy Journal 31, no. 4 (2010): 637–691, at 638; A. de Paor and N. Lowndes, “Tracing the History, Evolution and Future of Genetic Science and Technology,” in G. Quinn, A. de Paor and P. Blanck, eds., Genetic Discrimination: Transatlantic Perspectives on the Case for a European Level Legal Response (London: Routledge, 2014): 11-35; Roy and Tevfik Dorak, supra note 7; C. Diver and J. Maslow Cohen, “Genophobia: What Is Wrong with Genetic Discrimination?” University of Pennsylvania 149, no. 5 (2001): 1439-1482, at 1440, 1451.Google Scholar

de Paor, A. and O’Mahony, C., “The Need to Protect Employees with Genetic Predisposition to Mental Illness? The UN Convention on the Rights of Persons with Disabilities and the Case for Regulation,” Industrial Law Journal 45, no. 4 (2016): 525– 555.CrossRefGoogle Scholar

Lervasi, K., “Life Insurance Cost: What’s the Average Cost of Life Insurance?” Finder, available at <https://www.finder.com/average-cost-of-life-insurance#learn> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

The Price of Life Insurance (in Canada), Ratehub, available at <https://www.ratehub.ca/insurance/life/cost-of-life-insurance> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

Laycock, R., “How Much Is Life Insurance?” Finder AU, available at <https://www.finder.com.au/weekly-cost-life-insurance> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

US – 22% of families have no savings. T. Knutson, “Nielsen: Even Many High Earners Live Paycheck to Paycheck,” Financial Advisor, August 6, 2015, available at <https://www.fa-mag.com/news/nielsen--even-many-high-earners-live-paycheck-to-paycheck-22704.html?mod=article_inline> (last visited November 3, 2021); Canada – 53%: “BDO Canada Affordability Index 2019,” available at <https://debtsolutions.bdo.ca/our-people/bdo-in-the-news/bdo-canada-affordability-index-2019/>; Australia – 40%: “Household Financial Comfort Dragged Down by Residential Property Price Falls and Weakening Labour Market,” Members Equity Bank Limited, August 12, 2019, available at <https://www.mebank.com.au/news/household-financial-comfort-dragged-down/> (last visited November 3, 2021); UK – 31%: “Almost One Third of British Workers Live Paycheck to Paycheck, CareerBuilder.co.uk Survey Finds,” CareerBuilder UK, October 8, 2015, available at <https://hiring.careerbuilder.co.uk/news/almost-one-third-of-british-workers-live-paycheck-to-paycheck-careerbuilder.co.uk-survey-finds> (last visited November 3, 2021).+(last+visited+November+3,+2021);+Canada+–+53%:+“BDO+Canada+Affordability+Index+2019,”+available+at+;+Australia+–+40%:+“Household+Financial+Comfort+Dragged+Down+by+Residential+Property+Price+Falls+and+Weakening+Labour+Market,”+Members+Equity+Bank+Limited,+August+12,+2019,+available+at++(last+visited+November+3,+2021);+UK+–+31%:+“Almost+One+Third+of+British+Workers+Live+Paycheck+to+Paycheck,+CareerBuilder.co.uk+Survey+Finds,”+CareerBuilder+UK,+October+8,+2015,+available+at++(last+visited+November+3,+2021).>Google Scholar

Bruzelius, E., Scarpa, J., Zhao, Y., Basu, S., Faghmous, J., and Baum, A., “Huntington’s Disease in the United States: Variation by Demographic and Socioeconomic Factors,” Movement Disorders 34 (2019): 858–865.CrossRefGoogle ScholarPubMed

Id. Google Scholar

LIMRA, “Facts from LIMRA: Life Insurance Awareness Month, September 2014,” 2014, available at <https://www.limra.com/siteassets/newsroom/fact-tank/fact-sheets/limras-facts-about-life-2014> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

OECD, Improving Financial Education and Awareness on Insurance and Private Pensions (Paris: OECD Publishing 2008): at 40, available at <https://www-oecd-ilibrary-org.proxy.lib.uiowa.edu/docserver/9789264046399-en.pdf?expires=1588022075&id=id&accname=ocid177074&checksum=22070F15E7CB14DC171FF379F044DFDE> (access restricted).+(access+restricted).>Google Scholar

Gottlieb, D., “Prospect Theory, Life Insurance, and Annuities,” Working Paper No. 44, Department of Busisness & Public Policy, Univeristy of PennSylvania, 2012, available at < https://cpb-us-w2.wpmucdn.com/sites.wustl.edu/dist/c/547/files/2016/11/PT-Life-Insurance-and-Annuities-2g3rcto.pdf> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

Bernheim, B., Forni, L., Gokhale, J., and Kotlikoff, L., “The Mismatch between Life Insurance and Financial Vulnerabilities: Evidence from the Health and Retirement Survey,” American Economic Review 93, no. 1 (2003): 354–365.CrossRefGoogle Scholar

Balasubramanian, R., Chester, A., and Milinkovich, N., “Rewriting the Rules: Digital and AI-powered Underwriting in Life Insurance,” McKinsey & Company, July 31, 2020, available at <https://www.mckinsey.com/industries/financial-services/our-insights/rewriting-the-rules-digital-and-ai-powered-underwriting-in-life-insurance#> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

Lusardi, A. and Mitchell, O., “Financial Literacy around the World: An Overview,” Journal of Pension Economics and Finance 10 (2011): 497–508.CrossRefGoogle ScholarPubMed

Brinkman, R., Dubé, M., Rouleau, G., and Orr, A., “Human Monogenic Disorders — A Source of Novel Drug Targets,” Nature Reviews Genetics 7, no. 4 (2006): 249–260.CrossRefGoogle ScholarPubMed

Gutierrez, M. and Macdonald, A., “Huntington’s Disease, Critical Illness Insurance and Life Insurance,” Scandinavian Actuarial Journal (2004): 279–313.Google Scholar

Joly, Y., Dupras, C., Pinkesz, M., Tovino, S., and Rothstein, M., “Looking Beyond GINA: Policy Approaches to Address Genetic Discrimination,” Annual Review GINA: Policy Approaches to Address Genetic Discrimination 21 (2020): 491–507.Google ScholarPubMed

Association of British Insurers and Department of Health and Social Care, Her Majesty’s Government, supra note 35.Google Scholar

Genetic Non-Discrimination Act, supra note 18.Google Scholar

Lane, M., Ngueng, I., and Joly, Y., “Genetics and Personal Insurance: The Perspectives of Canadian Cancer Genetic Counselors,” Journal of Genetic Counseling 24 (2015): 1022–1036.CrossRefGoogle ScholarPubMed

Rupe, S., “Half of Consumers Think Life Insurance Not Relevant: AALU Survey,” Insurance News Net, November 6, 2019, available at <https://insurancenewsnet.com/innarticle/half-of-consumers-think-life-insurance-not-relevant-aalu-survey#.XqdL32hKg2x> (last visited November 3, 2021)+(last+visited+November+3,+2021)>Google Scholar

Howard, supra note 40.Google Scholar

Canadian Institute of Actuaries, Statement on Genetic Testing and Insurance, Document 214073 (June 2014), available at <https://www.cia-ica.ca/docs/default-source/2014/214073e.pdf> (last visited November 3, 2021).+(last+visited+November+3,+2021).>Google Scholar

Sheridan, M., “The STOLI Worm: A Practitioner’s Guide to Managing Life Settlements and Micro Longevity Risk,” (2019); Braun, A. and Xu, J., “Fair Value Measurement in the Life Settlement Market,” Journal of Fixed Income 29 (2020): 100–123.Google Scholar

Haçariz, O., Kleinow, T., Macdonald, A., Tapadar, P., and Thomas, R., “Will Genetic Test Results Be Monetized in Life Insurance?” Risk Management and Insurance Review 23 (2020): 379–399.CrossRefGoogle Scholar

Id.Google Scholar

See Doherty, N. and Singer, H., “The Benefits of a Secondary Market for Life Insurance Policies,” Real Property, Probate and Trust Journal 38 (2003): 449–478; Sheridan, supra note 103.Google Scholar

Durant, J. et al., “Public Understanding of the New Genetics,” in Marteau, T. and Richards, M., eds., The Troubled Helix: Social and Psychological Implications of the New Human Genetics (Cambridge: Cambridge University Press 1996): at 235–248; D. Allain, S. Friedman, and L. Senter, “Consumer Awareness and Attitudes about Insurance Discrimination Post Enactment of the Genetic Information Nondiscrimination Act,” Familial Cancer 11, no. 4 (2012): 637- 644.CrossRefGoogle Scholar

Kung, J. and Wu, C.T., “Leveling the Playing Field: Closing the Gap in Public Awareness of Genetics between the Well Served and Underserved,” Hastings Center Report 46, no. 5 (2016): 17–20.CrossRefGoogle ScholarPubMed

de Paor, A., Genetics, Disability and the Law – Towards a European Union Legal Framework (Cambridge: Cambridge University Press, 2017): at 289.CrossRefGoogle Scholar

U.N.E.S.C.O., International Declaration on Human Genetic Data, at Article 24 (Oct. 16, 2003); U.N.E.S.C.O., Universal Declaration on Bioethics and Human Rights, at Article 25 (Oct. 19, 2005); U.N. Convention on the Rights of Persons with Disabilities, Article 8, U.N. Doc. A/RES/61/106 (Dec. 13, 2006).Google Scholar

Joly, Y. et al., “Establishing the Genetic Discrimination Observatory,” Nature Genetics 52 (2020): 466– 468.CrossRefGoogle ScholarPubMed

de Paor, supra note 109, at 289.Google Scholar

Prince, A., “Comprehensive Protection of Genetic Information One Size Privacy of Property Models May Not Fit All,” Brooklyn Law Review 79, no. 1 (2013): 175–228.Google Scholar